Jodi A. Flaws

24.3k total citations · 5 hit papers
343 papers, 18.4k citations indexed

About

Jodi A. Flaws is a scholar working on Health, Toxicology and Mutagenesis, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Jodi A. Flaws has authored 343 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Health, Toxicology and Mutagenesis, 69 papers in Public Health, Environmental and Occupational Health and 66 papers in Genetics. Recurrent topics in Jodi A. Flaws's work include Effects and risks of endocrine disrupting chemicals (177 papers), Reproductive Biology and Fertility (57 papers) and Estrogen and related hormone effects (56 papers). Jodi A. Flaws is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (177 papers), Reproductive Biology and Fertility (57 papers) and Estrogen and related hormone effects (56 papers). Jodi A. Flaws collaborates with scholars based in United States, Brazil and Sweden. Jodi A. Flaws's co-authors include Patrick R. Hannon, Gail S. Prins, R. Thomas Zoeller, Andrea C. Gore, Jorma Toppari, Vesna A. Chappell, Suzanne E. Fenton, Ãngel Nadal, Maura K. Whiteman and Lisa Gallicchio and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Jodi A. Flaws

336 papers receiving 18.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

2015 1.6k citations Jodi A. Flaws et al. profile →
Defects in regulation of apoptosis in caspase-2-deficient mice

1998 560 citations Jodi A. Flaws et al. profile →
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

2001 515 citations Yadong Cui, Jodi A. Flaws et al. profile →
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

2015 464 citations Jodi A. Flaws et al. profile →
Bisphenol A and Reproductive Health: Update of Experimental and Human Evidence, 2007–2013

2014 429 citations Jackye Peretz, Russ Hauser et al. profile →

Peers

Countries citing papers authored by Jodi A. Flaws

Since Specialization

Citations

This map shows the geographic impact of Jodi A. Flaws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi A. Flaws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi A. Flaws more than expected).

Fields of papers citing papers by Jodi A. Flaws

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi A. Flaws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi A. Flaws. The network helps show where Jodi A. Flaws may publish in the future.

Co-authorship network of co-authors of Jodi A. Flaws

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi A. Flaws. A scholar is included among the top collaborators of Jodi A. Flaws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi A. Flaws. Jodi A. Flaws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bayesian benchmark dose modeling analysis and derivation of points of departure for female reproductive toxicity following exposure to di(2-ethylhexyl) phthalate (DEHP) — effects on reproductive hormones, folliculogenesis and estrous cyclicity 2025 ·Toxicological Sciences ·(unknown), (unknown), Mattias Öberg, Mary J. Laws, Patrick R. Hannon, Jodi A. Flaws, Pauliina Damdimopoulou	1
2	Phthalate monoesters affect membrane fluidity and cell-cell contacts in endometrial stromal adherent cell lines and spheroids 2024 ·Reproductive Toxicology ·Darja Lavõgina, (unknown), Sergei Kopanchuk, (unknown), Mary J. Laws, Jodi A. Flaws, Theodora Kunovac Kallak, Matts Olovsson, Pauliina Damdimopoulou, Andres Salumets	3
3	Effects of early life exposure to di(2-ethylhexyl) phthalate on jejunal morphology, sucrase activity, and colonic microbiota composition in young pigs 2024 ·Marcia H. Monaco, (unknown), Mei Wang, Jodi A. Flaws, Joseph Irudayaraj, Isaac Cann, Sharon M. Donovan	0
4	The effect of TiO2 nanoparticles on antral follicles is dependent on the nanoparticle internalization rate 2024 ·Toxicological Sciences ·(unknown), L. Peña, Jodi A. Flaws, Isabel Hernández‐Ochoa	1
5	In silico investigation of the role of miRNAs in a possible developmental origin of prostate cancer in F1 and F2 offspring of mothers exposed to a phthalate mixture 2024 ·Environmental Toxicology ·Antonio M. Aquino, (unknown), (unknown), (unknown), (unknown), (unknown), Luı́s Fernando Barbisan, Luís Antônio Justulin, Jodi A. Flaws, Wellerson Rodrigo Scarano	2
6	Phthalates and sex steroid hormones across the perimenopausal period: A longitudinal analysis of the Midlife Women’s Health Study 2024 ·Environment International ·(unknown), Paige L. Williams, Emma V. Preston, Li Zhong, Rebecca L. Smith, Rita S. Strakovsky, Shruthi Mahalingaiah, Russ Hauser, Jodi A. Flaws, Tamarra James‐Todd	6
7	Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation 2023 ·Chemosphere ·(unknown), (unknown), Sérgio Alexandre Alcântara dos Santos, (unknown), Luı́s Fernando Barbisan, Amina Bedrat, Luís Antônio Justulin, Jodi A. Flaws, Bernardo Lemos, Wellerson Rodrigo Scarano	5
8	Ovarian antral follicles metabolize imidacloprid in vitro 2023 ·Toxicological Sciences ·Vasiliki E. Mourikes, (unknown), (unknown), Mary J. Laws, Alexander Ulanov, Michael R. La Frano, Jodi A. Flaws	5
9	Ovarian volume partially explains associations of phthalate biomarkers with anti-Müllerian hormone and estradiol in midlife women 2023 ·Environment International ·(unknown), Diana C. Pacyga, Elnur Babayev, Francesca E. Duncan, Zhong Li, Paige L. Williams, Jodi A. Flaws, Rita S. Strakovsky	8
10	Imidacloprid and Its Bioactive Metabolite, Desnitro-Imidacloprid, Differentially Affect Ovarian Antral Follicle Growth, Morphology, and Hormone Synthesis In Vitro 2023 ·Toxics ·Vasiliki E. Mourikes, (unknown), (unknown), Alison M. Neff, Mary J. Laws, Jodi A. Flaws	23
11	Iodoacetic acid exposure alters the transcriptome in mouse ovarian antral follicles 2022 ·Journal of Environmental Sciences ·Andressa Gonsioroski, Mary J. Laws, Vasiliki E. Mourikes, Alison M. Neff, Jenny Drnevich, Michael J. Plewa, Jodi A. Flaws	8
12	Urinary phthalate metabolite concentrations and hot flash outcomes: Longitudinal associations in the Midlife Women's Health Study 2022 ·Environmental Research ·(unknown), Paige L. Williams, Zhong Li, Rebecca L. Smith, Rita S. Strakovsky, Russ Hauser, Jodi A. Flaws, Tamarra James‐Todd	4
13	Racial differences in lifestyle, demographic, and health factors associated with quality of life (QoL) in midlife women 2021 ·SHILAP Revista de lepidopterología ·Brandi Patrice Smith, (unknown), Jodi A. Flaws, Zeynep Madak‐Erdogan, Rebecca L. Smith	5
14	Early-Life Exposure to Environmental Contaminants Perturbs the Sperm Epigenome and Induces Negative Pregnancy Outcomes for Three Generations via the Paternal Lineage 2021 ·Epigenomes ·(unknown), Mathieu Dalvai, Romain Lambrot, Astrid Deschênes, Marie‐Pier Scott‐Boyer, Serge McGraw, Donovan Chan, Nancy Côté, Ayelet Ziv‐Gal, Jodi A. Flaws, Arnaud Droit, Jacquetta M. Trasler, Sarah Kimmins, Janice L. Bailey	14
15	Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling 2019 ·Cancer Research ·Zeynep Madak‐Erdogan, (unknown), Yiru Zhao, Brandi Patrice Smith, Eylem Kulkoyluoglu‐Cotul, Qianying Zuo, (unknown), (unknown), Gianluigi Rossi, Rebecca L. Smith, Sung Hoon Kim, John A. Katzenellenbogen, (unknown), Meera Patel, Natascia Marino, Anna Maria Storniolo, Jodi A. Flaws	86
16	Hormone variability and hot flash experience: Results from the midlife women’s health study 2018 ·Maturitas ·Catheryne Chiang, Lisa Gallicchio, Howard A. Zacur, (unknown), Jodi A. Flaws, Rebecca L. Smith	15
17	Risk Factors for Extended Duration and Timing of Peak Severity of Hot Flashes 2016 ·PLoS ONE ·Rebecca L. Smith, Lisa Gallicchio, Susan R. Miller, Howard A. Zacur, Jodi A. Flaws	18
18	Acute and Chronic Effects of Oral Genistein Administration in Neonatal Mice1 2010 ·Biology of Reproduction ·(unknown), Juanmahel Dávila, Gail C. Ekman, Rachel N. Andrews, Steven L. Neese, Jackye Peretz, Kellie A. Woodling, William G. Helferich, Jhimly Sarkar, Jodi A. Flaws, Susan L. Schantz, Daniel R. Doerge, Paul S. Cooke	50
19	Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy 1999 ·American Journal of Hematology ·Maura K. Whiteman, Yadong Cui, Jodi A. Flaws, Mark A. Espeland, Trudy L. Bush	11
20	Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy 1999 ·American Journal of Hematology ·Maura K. Whiteman, Yadong Cui, Jodi A. Flaws, Mark A. Espeland, Trudy L. Bush	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact